News
The viral Ice Bucket Challenge originated in 2014 benefiting the ALS Foundation. Now, it's been rebranded to support mental ...
The global amyotrophic lateral sclerosis market is on an upward trajectory, demonstrating significant potential for growth and innovation. According to the latest insights from Future Market Insights ...
Bradford Smith, who has ALS, became the first person with the condition to use Neuralink to type with brainpower alone.
A man with ALS received a Neuralink BCI implant, allowing him to control a laptop cursor and generate his own voice using AI.
An amyotrophic lateral sclerosis (ALS) diagnosis is often viewed as getting a death sentence. After diagnosis, people with ...
Ferrer’s R&D work focuses on neurological and pulmonary diseases, and the Spanish pharma has bought into ALS assets in the ...
Advocates for patients with amyotrophic lateral sclerosis — a fatal condition known as Lou Gehrig’s disease — urged lawmakers ...
Brad Smith, who is the first person with ALS and third to receive a Neuralink brain implant, shared his experience with the ...
Amyotrophic lateral sclerosis (ALS) is a disease that destroys the nerves necessary for movement. About 30,000 people in the ...
Abnormal kinase signaling can promote other harmful traits, such as neuroinflammation and neuronal cell death. On the other ...
Boston College baseball lost the third game of its series against Miami at Fenway Park on Sunday in the annual ALS Awareness ...
Prilenia inks agreement with Ferrer to commercialize and co-develop pridopidine in Europe and other select markets: Naarden, Netherlands Tuesday, April 29, 2025, 12:00 Hrs [IST] P ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results